Differentiation between stoichiometric and anticatalytic antioxidant properties of benzoic acid analogues: a structure/redox potential relationship study.
We investigated the antioxidant activities of some phenolic acid derivatives on a cell free system and on cellular and enzymatic models involved in inflammation. The stoichiometric antioxidant activities of phenolic acid derivatives were studied by measuring their capacity to scavenge the radical cation 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS(+)) and reactive oxygen species (ROS) produced by stimulated neutrophils. The anticatalytic antioxidant capacity of the molecules was evaluated on the activity of myeloperoxidase (MPO), an oxidant enzyme present in and released by the primary granules of neutrophils. The ROS produced by PMA-stimulated neutrophils were measured by lucigenin-enhanced chemiluminescence (CL) and the potential interaction of the molecules with MPO was investigated without interferences due to medium by Specific Immuno-Extraction Followed by Enzyme Detection (SIEFED). The antioxidant activities of the phenolic compounds were correlated to their redox potentials measured by differential pulse voltammetry (DPV), and discussed in relation to their molecular structure. The ability of the phenolic molecules to scavenge ABTS radicals and ROS derived from neutrophils was inversely correlated to their increased redox potential. The number of hydroxyl groups (three) and their position (catechol) were essential for their efficacy as stoichiometric antioxidants or scavengers. On MPO activity, the inhibitory capacity of the molecules was not really correlated with their redox potential. Likewise, for the inhibition of MPO activity the number of OH groups and mainly the elongation of the carboxylic group were essential, probably by facilitating the interaction with the active site or the structure of the enzyme. The redox potential measurement, combined with ABTS and CL techniques, seems to be a good technique to select stoichiometric antioxidants but not anticatalytic ones, as seen for MPO, what rather involves a direct interaction with the enzyme.
Center for Oxygen Research and Development, Institute of Chemistry B6a, University of Liège, 4000 Liège, Belgium; Department of Clinical Sciences, Equine Clinic, Veterinary Institute B41, University of Liège, 4000 Liège, Belgium. Electronic address: t.franck@ulg.ac.be.
Thierry
T
Franck
Ange
A
Mouithys-Mickalad
Thierry
T
Robert
Gianangelo
G
Ghitti
Ginette
G
Deby-Dupont
Philippe
P
Neven
Didier
D
Serteyn
D000818:Animals; D000975:Antioxidants / Q000737:chemistry* / Q000494:pharmacology; D019817:Benzoic Acid / Q000737:chemistry* / Q000494:pharmacology; D002396:Catechols / Q000737:chemistry; D002474:Cell-Free System; D055664:Electrochemical Techniques; D005707:Gallic Acid / Q000494:pharmacology; D006736:Horses; D008163:Luminescent Measurements; D009504:Neutrophils / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D010084:Oxidation-Reduction; D009195:Peroxidase / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism
D000975:Antioxidants; D002396:Catechols; D017382:Reactive Oxygen Species; D005707:Gallic Acid; D019817:Benzoic Acid; D009195:Peroxidase; C034221:catechol
Anticatalytic; Antioxidant; Benzoic acids; Myeloperoxidase; Stoichiometric; Voltammetry